• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Medgadget Visits Healthcareᐩ Expo Taiwan

      Medgadget Visits Healthcareᐩ Expo Taiwan

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

    • Radiology
      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Mining Ultrasound Data to Improve Liver Diagnostics: Interview with Beth Rogozinski, CEO at Oncoustics

      Mining Ultrasound Data to Improve Liver Diagnostics: Interview with Beth Rogozinski, CEO at Oncoustics

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Electrospun Construct Mimics Elasticity of Blood Vessels

      Electrospun Construct Mimics Elasticity of Blood Vessels

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

      FDA-Approved At-Home Spirometer: Interview with Charvi Shetty, Co-Founder and CEO at Aluna

      FDA-Approved At-Home Spirometer: Interview with Charvi Shetty, Co-Founder and CEO at Aluna

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Insulin Glargine Market Size to Grow US$ 6,257.7 Million, [Future SCOPE] Booming Worldwide by 2028 at a CAGR of 0.2% 

December 13th, 2022 Coherent Market Insights Releases

A synthetic, long-acting alternative to human insulin is insulin glargine. It functions by taking the place of the body’s natural insulin and assisting in the transfer of blood sugar into other bodily tissues where it is converted to energy. Insulin glargine is used, like other forms of insulin, to maintain blood sugar levels that are close to normal. Adults with type 1 diabetes, children with type 1 diabetes, and adults with type 2 diabetes may be treated with insulin glargine, according to the FDA (Food and Drug Administration). A basal insulin level is provided throughout the day by this long-acting insulin, which is administered once daily. It is a reformulated version of basal or long-acting insulin used to manage hyperglycemia in people with diabetes mellitus. Consequently, there is a rise in the demand for insulin.

Request For Sample Report (Including Full TOC, Table & Figures) @
https://www.coherentmarketinsights.com/insight/request-sample/5231

Market Drivers:

Over the course of the forecast period, more clinical studies and more R&D are anticipated to fuel the expansion of the worldwide insulin glargine market. For instance, Lannett has fulfilled its commitment to begin a pivotal clinical trial for its proposed interchangeable biosimilar competitor to Lantus by the end of March 2022 as it plans to file for and launch its insulin glargine product in the United States in 2023. Lannett has partnered with HEC Group on this project. The Lannett biosimilar’s reference biologic, Lantus, has also received permission for usage in the United States.

Market Opportunities:

Because diabetes is becoming more common worldwide, the demand for insulin glargine is likely to rise, providing profitable prospects for market participants. For instance, more than 537 million individuals (20-79 years old) have diabetes, according to the International Diabetes Federation (IDF). Furthermore, it is anticipated that 643 million people would have diabetes by 2030 and 783 million by 2045. Furthermore, type 2 diabetes is more likely to occur in 541 million persons. As a result, it is anticipated that demand for insulin glargine would rise globally.

Due to their weakened immune systems, persons with diabetes are more likely than those without concomitant conditions to develop significant consequences from COVID-19. Higher fatality rates and longer hospital admissions have been associated with diabetes and poorly controlled glucose levels in COVID-19 patients. According to several research, people who get COVID-19 may be more likely to develop diabetes.

Key Takeaways:

The market for insulin glargine was valued at US$6,153.5 million in 2021, and it is anticipated that it would grow at a CAGR of 0.2% from 2022 to 2028 to reach US$6,257.7 million.

Type Lantus held a leading position in the worldwide market for insulin glargine in 2021, accounting for 42.7% of the market’s value share. Increasing approval and the introduction of new products are anticipated to fuel segment expansion throughout the forecast period.

Market Trends

The global market for insulin glargine is anticipated to develop as public knowledge of managing diabetes rises. The first step in controlling and preventing diabetes is understanding it. To assist people with diabetes and those who provide care for them in making educated decisions about their illness, the International Diabetes Federation’s School of Diabetes has created a new online learning environment.

The global market for insulin glargine is anticipated to increase rapidly as a result of frequent approvals and launches of innovative medicines. For instance, Novo Nordisk’s Rybelsus (oral semaglutide) was given marketing authorization by the European Commission in April 2020 to treat persons with type II diabetes that is not well managed. The United Kingdom and all other members of the European Union are covered by the marketing authorization.

Download PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/5231

Competitive Landscape

The market for insulin glargine is dominated by companies like Julphar, Biocon, Eli Lilly, Sanofi Aventis, and Novo Nordisk AS, among others.

Recent Developments

Tirzepatide produced improved A1C and body weight reductions from baseline in persons with type-2 diabetes and elevated cardiovascular risk, according to a recent announcement by Eli Lilly & Company in November 2021.

The introduction of Semglee (insulin glargine injection) in vial and pre-filled pen presentations in the United States, authorised to treat people with diabetes, was announced by Biocon Biologics India Ltd. and Mylan N.V. in August 2020.

Reasons to buy this Insulin Glargine Market Report

☑ It attempts an analysis of the competing scenario.

☑ The current and exceptional product revenue market.

☑ An in-depth data on the regional investigation and competitive landscape structure.

☑ It benefits in creating an awareness of the important key product segments.

☑ The marketing strategies, opportunities, and development factors are explained.

☑ Insulin Glargine market size estimation and recent advancements in the industry are explained.

offer

Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5231

Table of Content

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Type
      • Market Snapshot, By Geography
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Increasing prevalence of diabetes worldwide
      • High cost of insulin glargine
      • Increase in awareness about diabetes management
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Insulin Glargine Market– Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact
  5. Global Insulin Glargine Market, By Type, 2017-2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2022 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Insulin Glargine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  6. Global Insulin Glargine Market, By Geography, 2017-2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2022 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
    • Middle East and Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
    • Rest of World
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  7. Competitive Landscape
    • Julphar
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Biocon
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eli Lilly
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi Aventis
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novo Nordisk AS
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Analyst Views
  8. Section
    • Research Methodology
    • About us

Related Reports

Injectable drugs market analysis

Human insulin drug market analysis

Pediatric nutrition market analysis

Generic sterile injectable market analysis

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact us:

Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com

Sign up and submit a press release

Sponsored
New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

Clarius Marketplace Unlocks the Power of AI Innovation for Ultrasound Imaging

Clarius Marketplace Unlocks the Power of AI Innovation for Ultrasound Imaging

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email